Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

ER Self-Test could catch cervical cancer earlier

NCT ID NCT07345897

First seen Jan 16, 2026 · Last updated Jun 21, 2026 · Updated 28 times

Summary

This study tests whether offering a self-sampling kit for HPV in the emergency department can increase the number of people who get screened for cervical cancer. About 200 eligible individuals (ages 30-65 with a cervix) will be offered the kit while in the ED. The goal is to see if more people follow through with screening compared to usual care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER SCREENING are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Rochester Strong Memorial Hospital

    RECRUITING

    Rochester, New York, 14642, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

self-sampling kit for HPV testing

What this could lead to

If successful, this approach could make cervical cancer screening more accessible and convenient, potentially catching more cases early.

What could go wrong

This is a small, early-stage study focused on feasibility, not on detecting cancer itself. The self-sampling method may not be as accurate as a clinician-collected sample, and results may not apply to all populations.

Conditions

The condition(s) this trial relates to.

cervical cancer human papilloma virus infection Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.